Literature DB >> 7147093

Cellular heterogeneity in human ovarian carcinoma studied by density gradient fractionation.

W J Mackillop, R N Buick.   

Abstract

We have utilized equilibrium density gradient sedimentation to document the cellular heterogeneity existing in tumor cell populations obtained from malignant ascites of 5 patients with serous ovarian carcinoma. The cellular properties defined were density, proliferative status (labelling index), clonogenic potential and accumulation of cytoplasmic fat droplets (oil-red O), and cytoplasmic RNA (methylgreen pyronin). Cells of like properties were found to have similar density in different patients. On the basis of density distributions, two broad populations could be identified: first, non-proliferative, non-clonogenic, differentiated cells of high density, and second, a lower density population showing infrequent evidence of differentiation, but containing all cells identified as proliferative by the labelling index and all cells with clonogenic capacity in agar culture. The data are discussed in terms of the support which they give to the view of human ovarian carcinoma as a stem cell system.

Entities:  

Mesh:

Year:  1982        PMID: 7147093

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 0250-6793            Impact factor:   6.277


  6 in total

1.  Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.

Authors:  L Bover; M Barrio; I Slavutsky; A I Bravo; C Quintans; A Bagnăti; B Lema; J Schiaffi; R Yomha; J Mordoh
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

2.  Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

Authors:  F L Meyskens; S P Thomson; J Buckmeier
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

3.  Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.

Authors:  G Chen; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies.

Authors:  G Dotsikas; T Konowalchuk; P P Major; P E Kovac; G K Ward; S S Stewart; G B Price; M M Elhilali; W J Mackillop
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

5.  Human ovarian carcinoma: evidence for patient-related differences in susceptibility to cytotoxic effectors that attack different cellular subpopulations within a tumour.

Authors:  D A Clark; H W Hirte; R N Buick
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

6.  The estimation of self-renewal in the clonogenic cells of human solid tumours: a comparison of secondary plating efficiency and colony size.

Authors:  J P Bizzari; W J Mackillop
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.